The percentage of PD-L1 positive immune cells in TME had no relationship with age, tumor size, lymph node metastasis, cTNM stage, histological grade, ER/PR and HER-2, Ki-67 index and molecular subtype (Table 2). This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.